Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Relli

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Human Genomics|July 29, 2015
Epigenetic inheritance and the missing heritabilityMarco Trerotola, Valeria Relli, Pasquale Simeone, et al.
Trends in Molecular Medicine|June 4, 2019
Abandoning the Notion of Non-Small Cell Lung CancerValeria Relli, Marco Trerotola, Emanuela Guerra, et al.
Oncotarget|November 27, 2018
Distinct lung cancer subtypes associate to distinct drivers of tumor progressionValeria Relli, Marco Trerotola, Emanuela Guerra, et al.
Frontiers in Oncology|March 18, 2026
The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cellsMarzia Deserti, Simone Sabbioni, Francesca Poli, et al.
Ageing Research Reviews|June 15, 2025
Molecular hydrogen therapy: A "democratic" emerging strategy against aging and age-related diseasesGiovanni Brandi, Chiara Delbaldo, Marzia Deserti, et al.
International Journal of Molecular Sciences|June 13, 2025
Mutant p53 Associates with Human Equilibrative Nucleoside 1 Upregulation and Better Response to Adjuvant Gemcitabine in Intrahepatic Cholangiocarcinoma PatientsMarzia Deserti, Valeria Relli, Andrea Palloni, et al.
Cancers|November 7, 2020
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and FailuresAlessandro Rizzo, Simona Tavolari, Angela Dalia Ricci, et al.
Cancers|July 29, 2023
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 AntibodyEmanuela Guerra, Marco Trerotola, Valeria Relli, et al.
BMC Medical Genetics|November 19, 2020
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial clusterGiovanni Brandi, Alessandro Rizzo, Marzia Deserti, et al.
Scientific Reports|February 13, 2023
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot studyFrancesco Vasuri, Marzia Deserti, Angelo G Corradini, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Human Genomics|July 29, 2015
Epigenetic inheritance and the missing heritabilityMarco Trerotola, Valeria Relli, Pasquale Simeone, et al.
Trends in Molecular Medicine|June 4, 2019
Abandoning the Notion of Non-Small Cell Lung CancerValeria Relli, Marco Trerotola, Emanuela Guerra, et al.
Oncotarget|November 27, 2018
Distinct lung cancer subtypes associate to distinct drivers of tumor progressionValeria Relli, Marco Trerotola, Emanuela Guerra, et al.
Frontiers in Oncology|March 18, 2026
The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cellsMarzia Deserti, Simone Sabbioni, Francesca Poli, et al.
Ageing Research Reviews|June 15, 2025
Molecular hydrogen therapy: A "democratic" emerging strategy against aging and age-related diseasesGiovanni Brandi, Chiara Delbaldo, Marzia Deserti, et al.
International Journal of Molecular Sciences|June 13, 2025
Mutant p53 Associates with Human Equilibrative Nucleoside 1 Upregulation and Better Response to Adjuvant Gemcitabine in Intrahepatic Cholangiocarcinoma PatientsMarzia Deserti, Valeria Relli, Andrea Palloni, et al.
Cancers|November 7, 2020
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and FailuresAlessandro Rizzo, Simona Tavolari, Angela Dalia Ricci, et al.
Cancers|July 29, 2023
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 AntibodyEmanuela Guerra, Marco Trerotola, Valeria Relli, et al.
BMC Medical Genetics|November 19, 2020
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial clusterGiovanni Brandi, Alessandro Rizzo, Marzia Deserti, et al.
Scientific Reports|February 13, 2023
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot studyFrancesco Vasuri, Marzia Deserti, Angelo G Corradini, et al.
Pageof 2